External Validation of Risk Scores for Predicting Venous Thromboembolism in Ambulatory Patients with Lung Cancer
The Khorana score with the 2-point threshold was validated in ambulatory patients with lung cancer, with the results indicating a decline in its discriminatory capability over time (at 12 months vs. 6 months from diagnosis). The CONKO score at the original 2-point threshold showed a stronger discriminatory capability but further validation with a larger sample size is recommended. The identified predictors should be further investigated in future research.
Authors
- Gregory M. Peterson (ORCID: https://orcid.org/0000-0002-6764-3882)
- Indira Samarawickrema (ORCID: https://orcid.org/0000-0003-4659-170X)
- Phil Newman (ORCID: https://orcid.org/0000-0001-5999-4001)
- Desmond Yip (ORCID: https://orcid.org/0000-0002-2806-2401)
- Mark Naunton (ORCID: https://orcid.org/0000-0002-6422-7170)
- Reza Mortazavi (ORCID: https://orcid.org/0000-0001-8885-0891)
- Ann‐Rong Yan (ORCID: https://orcid.org/0000-0003-2286-7943)
Institutions
- Australian National University (AU)
- University of Tasmania (AU)
- University of Canberra (AU)
- Canberra Hospital (AU)
Publication Details
- Journal
- Cancers
- Published
- 2024-09-15
- DOI
- https://doi.org/10.3390/cancers16183165
- Citations
- 2
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.10
Funders
- ACT Government
- University of Canberra